El-Muna, Najiya (2024) Evaluation of Antihypertensive Drug Use in Patients with Chronic Renal Failure Undergoing Hemodialysis at RSUD Dr. Moewardi Solo in 2022-2023. S1 Undergraduate thesis, Universitas Darussalam Gontor.

	FILE TEXT (COVER) 1. COVER.pdf - Submitted Version License Creative Commons Attribution Non-commercial No Derivatives. Download (986kB)
	FILE TEXT (ABSTRAK) 2. ABSTRAK.pdf - Submitted Version License Creative Commons Attribution Non-commercial No Derivatives. Download (318kB)
	FILE TEXT (DAFTAR ISI) 3. DAFTAR ISI.pdf - Submitted Version License Creative Commons Attribution Non-commercial No Derivatives. Download (334kB)
	FILE TEXT (BAB 1) 4. BAB 1.pdf - Submitted Version License Creative Commons Attribution Non-commercial No Derivatives. Download (535kB)
	FILE TEXT (BAB 2) 5. BAB 2.pdf - Submitted Version Exclusive to Registered users only License Creative Commons Attribution Non-commercial No Derivatives. Download (889kB)
	FILE TEXT (BAB 3) 6. BAB 3.pdf - Submitted Version Exclusive to Registered users only License Creative Commons Attribution Non-commercial No Derivatives. Download (558kB)
	FILE TEXT (BAB 4) 7. BAB 4.pdf - Submitted Version Exclusive to Registered users only License Creative Commons Attribution Non-commercial No Derivatives. Download (646kB)
	FILE TEXT (BAB 5) 8. BAB 5.pdf - Submitted Version Exclusive to Registered users only License Creative Commons Attribution Non-commercial No Derivatives. Download (197kB)
	FILE TEXT (DAFTAR PUSTAKA) 9. DAFTAR PUSTAKA.pdf - Submitted Version Exclusive to Registered users only License Creative Commons Attribution Non-commercial No Derivatives. Download (529kB)

Abstract

The purpose of antihypertensive use is to control blood pressure to slow the progression of kidney failure and prevent the onset of new complications. High blood pressure in patients with chronic kidney failure can accelerate the progression of kidney failure itself and give rise to new complications. This study aims to determine the use of antihypertensive drugs in patients with chronic kidney failure undergoing hemodialysis and to assess the use of antihypertensive drugs in patients with chronic kidney failure at Dr. Moewardi Solo Hospital in 2022–2023. The medical records are the subject of this retrospective descriptive observational research, which uses a purposive sampling approach. The sample in this study is 33 patients who meet the inclusion criteria. Based on information collected from 33 patients, 30% of them are female and 70% are male. With a result of 22%, anemia is the most common comorbidity in chronic kidney failure patients undergoing hemodialysis. With the number of patients undergoing hemodialysis once a week at 53% and 2 times a week at 36%, the frequency of hemodialysis varied across all patient samples. In patients with chronic renal failure, furosemide is the most effective antihypertensive drug in lowering blood pressure when used alone (12%), while candesartan and furosemide together (25%) are the most effective drugs when used in combination. Overall, it can be said that Dr. Moewardi Solo Hospital's assessment of the use of antihypertensive drugs in chronic kidney failure patients undergoing hemodialysis throughout 2022–2023 has been satisfactory.

View more statistics

View Item